Showing results (1821-1830 of 2,226) with videos related to

Sort By:
Pageof 223
Chembiochem : a European Journal of Chemical Biology|June 20, 2014
Structure-based design of new KSP-Eg5 inhibitors assisted by a targeted multicomponent reactionCarlos Carbajales, Miguel Ángel Prado, Hugo Gutiérrez-de-Terán, et al.
Metabolism: Clinical and Experimental|April 18, 2016
Computerized tomography measured liver fat is associated with low levels of N-terminal pro-brain natriuretic protein (NT-proBNP). Multi-Ethnic Study of AtherosclerosisOtto A Sanchez, Mariana Lazo-Elizondo, Irfan Zeb, et al.
Microorganisms|March 25, 2020
OXA-48 Carbapenemase in Klebsiella pneumoniae Sequence Type 307 in EcuadorJosé E Villacís, Jorge A Reyes, Hugo G Castelán-Sánchez, et al.
Current Therapeutic Research, Clinical and Experimental|November 22, 2017
Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis CDorta Guridi Zaily, Castellanos Fernandez Marlen, Dueñas-Carrera Santiago, et al.
Clinical & Translational Immunology|April 25, 2017
Screening for immune response against Dengue virus in Vietnamese non-human primates: implications for vaccine developersLaura Lazo Vázquez, Edith Suzarte Portal, Jorge Castro Velazco, et al.
Plos One|May 14, 2014
Comparative systems biology reveals allelic variation modulating Tocochromanol profiles in Barley (Hordeum vulgare L.)Rebekah E Oliver, Emir Islamovic, Donald E Obert, et al.
BMJ Open|February 17, 2024
User requirements for non-invasive and minimally invasive glucose self-monitoring devices in low-income and middle-income countries: a qualitative study in Kyrgyzstan, Mali, Peru and TanzaniaElvis Safary, David Beran, Beatrice Vetter, et al.
Immunology Letters|May 29, 2016
Dengue encephalitis-associated immunopathology in the mouse model: Implications for vaccine developers and antigens inducer of cellular immune responseErnesto Marcos, Laura Lazo, Lázaro Gil, et al.
BMJ (Clinical Research Ed.)|June 10, 2021
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trialMichael J Kovacs, Philip S Wells, David R Anderson, et al.
Veterinary Research|February 16, 2021
Humoral responses to SARS-CoV-2 by healthy and sick dogs during the COVID-19 pandemic in SpainAna Judith Perisé-Barrios, Beatriz Davinia Tomeo-Martín, Pablo Gómez-Ochoa, et al.
Pageof 223